United States · FDA National Drug Code directory
Cyproheptadine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76385-130_d68a0f7b-98e1-4d8c-a236-9d701e4e68d5
- Product NDC
- 76385-130
- Form
- TABLET
- Composition / generic term
- Cyproheptadine Hydrochloride
- Labeler
- UNICHEM PHARMACEUTICALS (USA), INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200301
- Source listing expiry
- 20271231
Source-listed ingredients
- CYPROHEPTADINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (76385-130-01) · 76385-130-01
- 1000 TABLET in 1 BOTTLE (76385-130-10) · 76385-130-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →